Intermittent Claudication News

SCAI: Iliac stents gain MOBILITY in treatment of PAD - Health Imaging



SCAI: Iliac stents gain MOBILITY in treatment of PAD 
Health Imaging
LAS VEGAS?When treating a real-world sample of patients for intermittent claudication or critical limb ischemia, two off-label iliac artery stents showed a statistically significant performance goal for low major adverse event rates, according to the ...

and more » 


Pluristem stem cells save girl's life - Chicago Tribune



Pluristem stem cells save girl's life 
Chicago Tribune
Pluristem recently received US FDA clearance to begin a Phase II clinical trial using the company's proprietary PLX-PAD cell product candidate intramuscularly for the treatment of Intermittent Claudication (IC), a subset of peripheral artery disease ...

and more » 


Pluristem stem cell therapy saves a patient, shares jump - Chicago Tribune



OneMedPlace 
Pluristem stem cell therapy saves a patient, shares jump 
Chicago Tribune
Last month, the US health regulators gave a go ahead to the company to start a mid-stage trial of the therapy for treating Intermittent Claudication -- a subset of peripheral artery disease. Pluristem shares, which have gained 5 percent since receiving ...
Compassionate Use of Pluristem's PLX Cells Saves the Life of a Child After ... MarketWatch (press release)

all 14 news articles » 


Stenting Safe in Aorto-Iliac Disease - MedPage Today



Stenting Safe in Aorto-Iliac Disease 
MedPage Today
Jaff noted that iliac artery stent trials generally don't include patients with intermittent claudication or critical limb ischemia. MOBILITY, however, did not shy away from these patients or those with very complex lesions. "Almost 100% of patients ...

and more » 


Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of ... - MarketWatch (press release)



Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of ... 
MarketWatch (press release)
The MOBILITY trial was designed to test the effectiveness of a self-expanding stent system and a balloon-expandable stent system in patients with intermittent claudication (IC) or critical limb ischemia (CLI) with even the most complex lesions.

and more » 


Pacific Therapeutics Ltd. Progress of Clinical Development - TheNewswire.ca (press release)



Pacific Therapeutics Ltd. Progress of Clinical Development 
TheNewswire.ca (press release)
The company's lead drug candidate PTL-202 is a combination of Pentoxifylline (a FDA approved drug used for treating intermittent claudication) and N-Acetyl-Cysteine (NAC) an amino acid and an extremely potent and important antioxidant.

 


Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of ... - Sacramento Bee



Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of ... 
Sacramento Bee
The MOBILITY trial was designed to test the effectiveness of a self-expanding stent system and a balloon-expandable stent system in patients with intermittent claudication (IC) or critical limb ischemia (CLI) with even the most complex lesions.

and more » 


CR Bard's CEO Discusses Q1 2012 Results - Earnings Call Transcript - Seeking Alpha



CR Bard's CEO Discusses Q1 2012 Results - Earnings Call Transcript 
Seeking Alpha
The study includes patients suffering from claudication or rest pain with significant stenosis in previously unstented vessels. We'll follow these patients for 5 years but anticipate PMA submission with one-year follow-up. We also have a 650-patient ...

 


Ginkgo biloba - effekt, bivirkninger og interaksjoner - RELIS



Ginkgo biloba - effekt, bivirkninger og interaksjoner 
RELIS
Ginkgo biloba for intermittent claudication (april 2009): Overall, there is no evidence that Ginkgo biloba has a clinically significant benefit for patients with peripheral arterial disease. Ginkgo biloba for tinnitus (mars 2010): The limited evidence ...